drugset / Trial / NCT06099652
Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of the study was to evaluate the efficacy and safety of 611 in Chinese adults with moderate to severe COPD.
Timeline
- Start
- 2023-12-08
- Primary completion
- 2025-04-15
- Completion
- 2025-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 611 | Unknown | 300 mg | Subcutaneous |
| Subject | 611 | Unknown | 450 mg | Subcutaneous |